drug tolerance

Type: Keyphrase

Name: drug tolerance

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

University of Massachusetts Medical School

Scientists develop new tool for analyzing and characterizing aspects of the brain's neural circuitry

Discovery provides model system for studying how the brain integrates multiple stimuli and initiates motor responseScientists at the University of Massachusetts Medical School have developed a novel transgenic system which allows them to remotely activate ... [Published News-Medical.Net - Jun 17 2013]

Entities: Neuron, Drosophila, University of Massachusetts Medical School, drug tolerance, pomace fly

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Karen Telleen-Lawton: Toll of Drug Overdose Hits Close to Home

I am a friend of facts. They are dependable, interesting and usually unpretentious. But sometimes facts are used for avoidance purposes. They can be abused to sidestep an issue that has become too personal.For instance, here are a few drug abuse facts. ... [Published Noozhawk.com - Jun 04 2013]

Entities: Heroin (Diacetylmorphine), Overdose, Drug Abuse, Drugs, Desired Effects

First reported May 28 2013 - Updated May 28 2013 - 1 reports

MedEnhanz gives doctors quicker access to drug information

An accessible web-based point of care drug reference platform has been launched to give physicians in Nigeria easier and faster access to drug information.MedEnhanz is a product of a partnership involving an e-commerce expert and a foreign-based Nigerian ... [Published HumanIPO - May 28 2013]

Entities: Drugs, Patient, drug tolerance, Pharmacogenetics, Pharmacokinetics

First reported May 22 2013 - Updated May 22 2013 - 1 reports

China New Aids Drug in Clinical Test

News from the official website of the Ministry of Education (MOE) said that new Aids drug Azvudine developed by Zhengzhou University has been approved for clinical test by the State Food and Drug Administration (SFDA), which will greatly lower medical ... [Published Individual.com - May 22 2013]

Entities: HIV/AIDS, drug tolerance, Drugs, China State Food & Drug Administration

First reported Feb 27 2013 - Updated Feb 27 2013 - 1 reports

Immunogenicity Session Spotlight: Highly Sensitive Non-Wash Immunoassays for Immunogenicity and PD/PK Studies

Severe adverse events to biologics are one of the very greatest fears facing the industry – even in a pre-marketing state, if they surface during clinical trials the public fear and reputational damage can be great enough to destroy the sponsor company ... [Published Future of BioPharma - Feb 27 2013]

Entities: ImmunoGen Inc, Anti-Drug, Serum, Assay, Antibody

First reported Jan 25 2013 - Updated Jan 25 2013 - 1 reports

MedImmune Inc

IIR’s Immunogenicity Event features exclusive case studies including Amgen, Medimmune, Merck Serono and more!

IIR’s 14th Annual Immunogenicity for Biotherapeutics features 10 case studies aimed at the greatest challenges you face every day in developing safer biologics across the preclinical and clinical spectrum. Hear from Amgen, Medimmune, Merck Serono, ... [Published Future of BioPharma - Jan 25 2013]

Entities: Merck Serono, MedImmune Inc, Amgen Inc, ImmunoGen Inc

First reported Jan 24 2013 - Updated Jan 24 2013 - 1 reports

Immunogenicity Session Spotlight: Using the Aushon BioSystems Technology to Develop a Sensitive, Drug Tolerant Screening Assay

With so many different varieties of assays available, it is important for bioanalytical professionals to weigh considerations such as sensitivity, precision, drug tolerance, and cost. In today's featured Immunogenicity for Biotherapeutics session spotlight, ... [Published Future of BioPharma - Jan 24 2013]

Entities: Assay, ImmunoGen Inc, drug tolerance, Drugs

Quotes

...Yoshihara, PhD, assistant professorprofessor of neurobiology at the University of Massachusetts Medical School and lead author of the Nature study. "By developing genetic tools to remotely activate individual brain cells in Drosophila, we've been able to isolate a pair of neurons that are critical to the act of eating in fruit flies. More importantly, we now have a powerful new tool with which we can answer important questions about the function and composition of neural circuitry."

Scientists develop new tool for analyzing and characterizing aspects of the brain's neural circuitry [Published News-Medical.Net - Jun 17 2013]

...become active in the presence of a food source for the fly, but the response was contingent on whether the animal was hungry," said Yoshihara. "This means that these neurons are integrating both internal and external stimuli in order to initiate a complex feeding behavior with multiple motor programs."

Scientists identify neurons that control feeding behavior in Drosophila [Published Medical Xpress - Jun 14 2013]

...project by supporting pre-clinical studies for the investigational new drug application," said Dr Gahl, who also serves as NHGRI clinical director. "The programme provides the missing link in the evolution of drug treatments. It is a resource that has the potential to develop new therapeutics for rare diseases, often with applicability to common disorders."

NIH scientists to conduct trial for rare degenerative muscle disease treatment [Published PharmaBiz - Sep 26 2012]

More Content

sort by: Date \| Relevance
Scientists develop new tool for analyzing and c... [Published News-Medical.Net - Jun 17 2013]
A proactive approach [Published thestar.com.my - Jun 16 2013]
Scientists identify neurons that control feedin... [Published Medical Xpress - Jun 14 2013]
Scientists at UMass Medical School identify neu... [Published EurekAlert! - Jun 14 2013]
Karen Telleen-Lawton: Toll of Drug Overdose Hit... [Published Noozhawk.com - Jun 04 2013]
MedEnhanz gives doctors quicker access to drug ... [Published HumanIPO - May 28 2013]
China New Aids Drug in Clinical Test [Published Individual.com - May 22 2013]
Immunogenicity Session Spotlight: Highly Sensit... [Published Future of BioPharma - Feb 27 2013]
IIR’s Immunogenicity Event features exclusive c... [Published Future of BioPharma - Jan 25 2013]
Immunogenicity Session Spotlight: Using the Aus... [Published Future of BioPharma - Jan 24 2013]
NIH scientists to conduct trial for rare degene... [Published PharmaBiz - Sep 26 2012]

Blogs

sort by: Date \| Relevance
Immunogenicity Session Spotlight: Highly Sensit... [Published Future of BioPharma - Feb 27 2013] Severe adverse events to biologics are one of the very greatest fears facing the industry – even in a pre-marketing state, if they surface during clinical trials the public fear and reputational damage can be great enough to destroy the sponsor company ...
IIR’s Immunogenicity Event features exclusive c... [Published Future of BioPharma - Jan 25 2013] IIR’s 14th Annual Immunogenicity for Biotherapeutics features 10 case studies aimed at the greatest challenges you face every day in developing safer biologics across the preclinical and clinical spectrum. Hear from Amgen, Medimmune, Merck Serono, ...
Immunogenicity Session Spotlight: Using the Aus... [Published Future of BioPharma - Jan 24 2013] With so many different varieties of assays available, it is important for bioanalytical professionals to weigh considerations such as sensitivity, precision, drug tolerance, and cost. In today's featured Immunogenicity for Biotherapeutics session spotlight, ...